# OnCo record braf-fusion (biomarker). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/biomarkers/braf-fusion/>
  a schema:MedicalTest ;
  onco:kind "biomarker" ;
  schema:identifier "braf-fusion" ;
  schema:name "BRAF fusion or rearrangement"@en ;
  schema:alternateName "BRAF fusion"@en, "KIAA1549-BRAF"@en, "KIAA1549::BRAF"@en, "BRAF rearrangement"@en, "BRAF-fused glioma"@en ;
  schema:description "A BRAF fusion joins another gene to the BRAF kinase, most often KIAA1549 in paediatric low-grade glioma. Tovorafenib is approved for children whose relapsed low-grade glioma carries a BRAF fusion or V600 mutation."@en ;
  schema:url <https://onco.cc/biomarkers/braf-fusion/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea3a9631-3a66-6a7c-e053-2995a90ae2ad> ;
  onco:tag "biomarker", "braf" ;
  onco:related <https://onco.cc/biomarkers/braf-v600e/>, <https://onco.cc/biomarkers/braf-class-ii-iii/> ;
  onco:cancers <https://onco.cc/cancers/paediatric-low-grade-glioma/>, <https://onco.cc/cancers/melanoma/> ;
  onco:drugs <https://onco.cc/drugs/tovorafenib/>, <https://onco.cc/drugs/foundationone-cdx/> ;
  onco:terms <https://onco.cc/terms/gene-fusion/>, <https://onco.cc/terms/braf-v600-mutation/> .